| 820 |
Centers for Disease Control and Prevention |
Html |
en |
H7N9 Testing Recommendations |
Interim Guidance for Infection Control Within Healthcare Settings When Caring for Patients with Confirmed, Probable, or Cases Under Investigation of Avian Influenza A(H7N9) Virus Infection - CDC |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5417 |
Centers for Disease Control and Prevention |
Html |
en |
The minigrant model: a strategy to promote local implementation of state cancer plans in Appalachian communities. |
null |
| Appalachian Development District | 0.422402 |
| Appalachian regional visibility | 0.419749 |
| state comprehensive cancer | 0.448477 |
| Tennessee State University | 0.470773 |
| Appalachian Cancer Forum | 0.467716 |
| Appalachian residents | 0.431774 |
| Appalachian cultural cancer | 0.470415 |
| Virginia CCC coalition | 0.417907 |
| statewide CCC coalitions | 0.477365 |
| project advisory work | 0.440721 |
| Appalachian communities | 0.690316 |
| CCC coalition representatives | 0.424539 |
| Appalachian region | 0.506739 |
| Appalachian community cancer | 0.555003 |
| CCC coalition members | 0.426578 |
| successful cancer control | 0.499652 |
| cancer control programs | 0.443197 |
| Appalachian regional partner | 0.428195 |
| local Appalachian communities | 0.561835 |
| Appalachian substate regions | 0.53058 |
| Appalachian states | 0.471207 |
| local Appalachian community | 0.644945 |
| ETSU project staff | 0.458716 |
| state CCC coalition | 0.512881 |
| state cancer plans | 0.56084 |
|
| regional CCC coalitions | 0.472679 |
| Appalachian community leaders | 0.429295 |
| state ccc coalitions | 0.765281 |
| death rates | 0.442242 |
| Appalachian | 0.694676 |
| cancer control | 0.800466 |
| substate CCC coalitions | 0.498869 |
| CCC activities | 0.424583 |
| comprehensive cancer control | 0.457698 |
| substate Appalachian region | 0.454406 |
| CCC coalition personnel | 0.431925 |
| CCC coalition activities | 0.428955 |
| East Tennessee State | 0.47242 |
| cancer control activities | 0.773936 |
| Appalachian populations | 0.420904 |
| cancer data | 0.461787 |
| Appalachian community organizations | 0.587956 |
| Appalachian Regional Commission | 0.473719 |
| similar state CCC | 0.438298 |
| state Appalachian cancer | 0.498615 |
| roundtables | 0.450903 |
| advisory work group | 0.441587 |
| local cancer control | 0.468621 |
| CCC coalitions | 0.904004 |
|
CLICK HERE |
| 5425 |
Centers for Disease Control and Prevention |
Html |
en |
WARNING: Cigarettes cause fatal lung disease. |
null |
| right web address | 0.987879 |
| Español | 0.403508 |
| Language Assistance | 0.712207 |
| Português | 0.391584 |
| Kreyòl Ayisyen | 0.700648 |
| Instructions | 0.282468 |
| different file formats | 0.919531 |
| Tiếng Việt | 0.70734 |
| Deutsch | 0.348548 |
| help | 0.283342 |
|
| РуÑ?Ñ?кий | 0.283258 |
| Polski | 0.39029 |
| Tagalog | 0.362008 |
| options | 0.298124 |
| Français | 0.385004 |
| Downloading Viewers | 0.795919 |
| العربية | 0.436655 |
| information | 0.283148 |
| page | 0.385868 |
|
CLICK HERE |
| 7747 |
Centers for Disease Control and Prevention |
Html |
en |
Bartonella - Distribution |
Bartonella bacteria cause several diseases in humans. The three most common are cat scratch disease, caused by B. henselae; trench fever, caused by B. quintana; and Carrión's disease, caused by B. bacilliformis.
|
| feline bartonellosis | 0.374061 |
| young cats | 0.390006 |
| wild animals | 0.372244 |
| clear B. henselae | 0.428277 |
| Bartonella spp | 0.567113 |
| dogs | 0.40709 |
| stray cats | 0.45072 |
| public health risk | 0.423614 |
| Bartonella-specific DNA sequences | 0.419757 |
| infected cat | 0.385787 |
| Domestic pets | 0.379402 |
| blood transfusions | 0.384975 |
| worldwide dog populations | 0.431517 |
| Bartonella species. Cats | 0.725152 |
| Low seroprevalence | 0.373307 |
| Bartonella vinsonii subsp. | 0.665489 |
| reservoir hosts | 0.371501 |
| febrile illness | 0.3708 |
| Bartonella infections | 0.58191 |
| Bartonella henselae bacteremia | 0.817882 |
| immunofluorescence antibodies | 0.369886 |
| massive vegetative lesions | 0.427566 |
| Bartonella henselae | 0.905746 |
| human infection | 0.401282 |
| B. henselae | 0.490219 |
|
| healthy cats. Cats | 0.473855 |
| infected fleas | 0.424076 |
| swollen lymph nodes | 0.43905 |
| cat fights | 0.37841 |
| natural reservoir | 0.372551 |
| subclinical carriers | 0.371013 |
| sensitive diagnostic tool | 0.421967 |
| various species | 0.379317 |
| Bartonella clarridgeiae | 0.629223 |
| Bartonella-associated endocarditis | 0.383056 |
| Bartonella transmission | 0.557791 |
| granulomatous rhinitis | 0.379713 |
| clinical symptoms | 0.50438 |
| younger cats | 0.401503 |
| clinical signs | 0.37334 |
| Bartonella exposure | 0.576929 |
| granulomatous lymphadenitis | 0.382715 |
| Bartonella species. Bartonella | 0.89558 |
| advocate declawing cats | 0.446087 |
| infected blood | 0.403904 |
| symptomatic pets | 0.370868 |
| B. vinsonii berkhoffii | 0.433625 |
| various Bartonella species | 0.656441 |
| B. henselae infections | 0.440485 |
|
CLICK HERE |
| 7812 |
Centers for Disease Control and Prevention |
Html |
en |
Radiation - Health Communication |
Gateway to Health Communication and Social Marketing Practice - Radiation |
| severe retinal burns | 0.513352 |
| terrorist event range | 0.529573 |
| nuclear detonation | 0.491582 |
| radioactive waste | 0.485649 |
| mental retardation | 0.470403 |
| national emergency-response plan | 0.511917 |
| large quantity | 0.465442 |
| extended period | 0.467215 |
| following precautionary measures | 0.506805 |
| bone marrow depletion | 0.502084 |
| great public alarm | 0.502786 |
| extremely large doses | 0.53871 |
| nuclear bomb | 0.516791 |
| exposure | 0.571501 |
| External exposure | 0.501362 |
| radioactive materials | 0.492781 |
| external radiation | 0.538092 |
| terrorist nuclear attack | 0.523719 |
| bodily injury | 0.465788 |
| health effects | 0.645985 |
| nuclear facility | 0.521052 |
| large region | 0.465275 |
| lower doses | 0.477527 |
| high levels | 0.471532 |
| blast site | 0.478901 |
|
| radioactive fallout | 0.490281 |
| electrical power | 0.471747 |
| adverse health effects | 0.637533 |
| severe skin burns | 0.514334 |
| internal exposure | 0.505988 |
| great psychological effects | 0.518635 |
| cause extensive contamination | 0.533197 |
| radioactive material | 0.633571 |
| acute radiation syndrome | 0.976989 |
| potential exposure | 0.495575 |
| large enough dose | 0.465572 |
| public health official | 0.509967 |
| radioactive contaminated material | 0.561532 |
| public health | 0.512188 |
| smaller doses | 0.48308 |
| major event | 0.465349 |
| small nuclear device | 0.620009 |
| beneficial uses | 0.470675 |
| people | 0.496637 |
| blast | 0.486333 |
| greater opportunity | 0.466252 |
| extreme cases | 0.467809 |
| dirty bomb | 0.521648 |
| Routine exposure | 0.496526 |
|
CLICK HERE |
| 8099 |
Centers for Disease Control and Prevention |
Html |
en |
Opioids drive continued increase in drug overdose deaths |
[Title] |
| educational programs | 0.271041 |
| CDC’s National | 0.276604 |
| research letter | 0.274572 |
| public insurance programs | 0.390935 |
| state-run health plans | 0.320072 |
| drug class | 0.284018 |
| prescription drug abuse | 0.460015 |
| Disease Control | 0.274952 |
| monitoring patients | 0.267506 |
| behavioral health | 0.270889 |
| federal government | 0.267109 |
| overdose deaths | 0.960226 |
| health care providers | 0.428586 |
| prescription drugs | 0.327926 |
| prescription drug | 0.586635 |
| opioid labeling | 0.323675 |
| steady rise | 0.267921 |
| CDC Director Tom | 0.328966 |
| compensation programs | 0.267211 |
| prescription drug monitoring | 0.428394 |
| state licensing boards | 0.311976 |
| Health Statistics | 0.276823 |
| multiple cause-of-death file | 0.322761 |
| high doses | 0.266204 |
|
| substance abuse treatment | 0.313318 |
| chronic pain management | 0.310855 |
| multiple times | 0.265049 |
| prescription opioid abuse | 0.413699 |
| United States | 0.406803 |
| anti-anxiety drugs | 0.291567 |
| CDC researchers | 0.276668 |
| antipsychotic drugs | 0.288282 |
| overdose deaths increase | 0.609417 |
| effective pain treatment | 0.30752 |
| death certificates | 0.264789 |
| drug overdose deaths | 0.843826 |
| pharmaceutical drugs | 0.291017 |
| opioid analgesics | 0.469284 |
| similar increase | 0.265438 |
| prescription drug overdose | 0.509777 |
| pharmaceutical overdose deaths | 0.821829 |
| abuse-deterrent opioid formulations | 0.381168 |
| prescription painkillers | 0.313581 |
| drug monitoring programs | 0.395779 |
| opioid therapy | 0.326822 |
| improper patient | 0.264658 |
| mental health conditions | 0.331373 |
| predominant role | 0.270234 |
|
CLICK HERE |
| 9080 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Researchers Highlight Lessons Learned from H3N2v, July 2011-April 2012 |
CDC Researchers Highlight Lessons Learned from H3N2v, July 2011-April 2012. |
| variant influenza viruses | 0.708011 |
| Clinical Infectious Diseases | 0.927793 |
| public health interventions | 0.63148 |
| mathematical models | 0.542516 |
| human cases | 0.567529 |
| H3N2v | 0.995868 |
| Dr. David Swerdlow | 0.640468 |
| H3N2v virus | 0.592409 |
| low levels | 0.549929 |
| young children | 0.553823 |
| pandemic influenza preparedness | 0.682897 |
| cross-reactive antibody | 0.549611 |
| age distribution changes | 0.648038 |
| H3N2v modeling studies | 0.693393 |
| modeling studies | 0.801003 |
| age distribution | 0.729729 |
| H3N2v illness | 0.596334 |
| highest risk | 0.544039 |
| public health strategies | 0.632912 |
| older children | 0.546919 |
| influenza outbreak | 0.611311 |
| journal Clinical Infectious | 0.690585 |
| H3N2v infections | 0.680057 |
| H3N2v cases | 0.697359 |
| influenza-like illness | 0.543244 |
|
| swine exposure | 0.691165 |
| ongoing relevant insight | 0.678055 |
| limited person-to-person transmission | 0.683339 |
| H3N2v infection | 0.594972 |
| large H3N2v outbreak | 0.712826 |
| care outbreaks | 0.552519 |
| polymerase chain reaction | 0.660361 |
| previously reported infections | 0.69075 |
| Dr. Lyn Finelli | 0.640521 |
| H3N2v transmission | 0.599796 |
| CDC studies | 0.59537 |
| CDC scientists | 0.565764 |
| influenza surveillance data | 0.701393 |
| costly control measures | 0.629771 |
| medical care | 0.540636 |
| Epperson et | 0.570343 |
| serologic studies | 0.557804 |
| minimal swine | 0.561283 |
| mitigating influenza illness | 0.677969 |
| mathematical model | 0.666624 |
| Infectious Diseases website | 0.638072 |
| larger H3N2v outbreak | 0.726558 |
| H3N2v outbreak | 0.809535 |
| H3N2v outbreaks | 0.629739 |
|
CLICK HERE |
| 10697 |
Centers for Disease Control and Prevention |
Html |
en |
Key Websites and Online Resources'Resources' Communicating in the First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 12468 |
Centers for Disease Control and Prevention |
Video |
en |
June 2013 ACIP Meeting -- Opening Remarks |
Opening remarks for June 2013 The U.S. Advisory Committee of Immunization Practices meeting hosted by Dr. Jon Temte and Dr. Larry Pickering.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=6d1740eceeb88604b828ba9580b53bc620130730140231828 |
|
|
CLICK HERE |
| 14266 |
Centers for Disease Control and Prevention |
Html |
en |
Revision to CDC's Zika Travel Notices: Minimal Likelihoodfor Mosquito-Borne Zika Virus Transmission at Elevations Above2,000 Meters | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| mosquito-borne Zika virus | 0.49069 |
| current geographic data | 0.274653 |
| digital elevation model | 0.276257 |
| high elevations | 0.357478 |
| Zika virus | 0.975944 |
| subnational travel alerts | 0.29057 |
| recent Zika virus | 0.376354 |
| pregnant women | 0.32562 |
| Ae. albopictus persistence | 0.274147 |
| unsuitable ecologic factors | 0.285582 |
| CDC Zika virus | 0.378211 |
| active Zika virus | 0.364392 |
| U.S. territories | 0.449295 |
| U.S. territory | 0.314913 |
| certain elevations | 0.28672 |
| Zika virus transmission.†| 0.362841 |
| Zika virus presence | 0.345251 |
| ongoing Zika virus | 0.57532 |
| Zika virus disease | 0.363585 |
| countries | 0.293195 |
| Ae. aegypti | 0.619436 |
| Zika travel notice | 0.300652 |
| Aedes aegypti mosquitoes | 0.356405 |
| Zika virus transmission | 0.782552 |
| dengue virus transmission | 0.337188 |
|
| American Health Organization | 0.274068 |
| quantifiable ecologic variable | 0.292117 |
| maternal Zika virus | 0.376159 |
| Aedes species | 0.286442 |
| human dengue cases | 0.282594 |
| geographic data | 0.306724 |
| Zika virus risk | 0.362547 |
| Zika virus transmission.** | 0.346021 |
| Zika virus cases | 0.401441 |
| multiple data sets | 0.277035 |
| predominant Zika virus | 0.361425 |
| subnational travel notices | 0.329482 |
| 100-m elevation segments | 0.275548 |
| ecologic factors | 0.330724 |
| precisely defined areas | 0.273576 |
| Zika virus transmission. | 0.342918 |
| elevations | 0.400045 |
| global data | 0.275892 |
| incomplete surveillance data | 0.277413 |
| global geographic data | 0.279566 |
| travel notices | 0.331982 |
| human population density | 0.332663 |
| alert travel notice* | 0.290794 |
| sea level | 0.277347 |
|
CLICK HERE |